BridgeBio Pharma, Inc.
SEC Filing List
BBIO CIK: 0001743881
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Kumar Neil | goodwin procter llp /fa | 09/21/2026 | |
| 8-K | Current report filing | Bridgebio Pharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 08/31/2026 | |
| 4 | Statement of changes in beneficial owner... | Kumar Neil | goodwin procter llp /fa | 08/20/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 08/19/2026 | ||
| 4 | Statement of changes in beneficial owner... | Trimarchi Thomas | goodwin procter llp /fa | 08/18/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 08/18/2026 | ||
| 4 | Statement of changes in beneficial owner... | Kumar Neil | goodwin procter llp /fa | 08/18/2026 | |
| 4 | Statement of changes in beneficial owner... | Apuli Maricel | goodwin procter llp /fa | 08/18/2026 | |
| 8-K | Current report filing | Bridgebio Pharma, Inc. | Broadridge Financial Solutions, Inc. /fa | 08/17/2026 | |
| SCHEDULE 13D/A | Broadridge Financial Solutions, Inc. /fa | 08/17/2026 | |||
| No record found. | |||||
| Load More | |||||
